Maintenance Treatment of Toripalimab(JS001) in Patients With Unresectable Locally Advanced or Metastatic Mucosal Melanoma

NCT04472806 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Mucosal Melanoma

Interventions

DRUG: Toripalimab
DRUG: chemotherapy in combination with Endostar

Sponsor

Fudan University

Collaborators

[object Object]
[object Object]
[object Object]